Cited by 138Neurogenesis and neuroplasticity mechanismsGenetics and Neurodevelopmental DisordersEpilepsy research and treatment

Loss of CDKL5 impairs survival and dendritic growth of newborn neurons by altering AKT/GSK-3β signaling

Open access
Fuchs, Claudia, Trazzi, Stefania, Torricella, Roberta, Viggiano, Rocchina, De Franceschi, Marianna, Amendola, Elena, Gross, Cornelius, Calzà, Laura +2 more·2014·Neurobiology of Disease

Abstract

Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5) gene have been identified in a neurodevelopmental disorder characterized by early-onset intractable seizures, severe developmental delay, intellectual disability, and Rett's syndrome-like features. Since the physiological functions of CDKL5 still need to be elucidated, in the current study we took advantage of a new Cdkl5 knockout (KO) mouse model in order to shed light on the role of this gene in brain development. We mainly focused on the hippocampal dentate gyrus, a region that largely develops postnatally and plays a key role in learning and memory. Looking at the process of neurogenesis, we found a higher proliferation rate of neural precursors in Cdkl5 KO mice in comparison with wild type mice. However, there was an increase in apoptotic cell death of postmitotic granule neuron precursors, with a reduction in total number of granule cells. Looking at dendritic development, we found that in Cdkl5 KO mice the newly-generated granule cells exhibited a severe dendritic hypotrophy. In parallel, these neurodevelopmental defects were associated with impairment of hippocampus-dependent memory. Looking at the mechanisms whereby CDKL5 exerts its functions, we identified a central role of the AKT/GSK-3β signaling pathway. Overall our findings highlight a critical role of CDKL5 in the fundamental processes of brain development, namely neuronal precursor proliferation, survival and maturation. This evidence lays the basis for a better understanding of the neurological phenotype in patients carrying mutations in the CDKL5 gene.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.nbd.2014.06.006

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Fuchs, C., Trazzi, S., Torricella, R., Viggiano, R., De Franceschi, M., Amendola, E., Gross, C., Calzà, L., Bartesaghi, R., & Ciani, E.
Affiliations
  • University of Bologna (IT)
  • European Molecular Biology Laboratory (IT)
Corresponding author
Ciani, Elisabetta
Venue
Neurobiology of Disease
Publisher
Elsevier BV
Published
2014-10
Volume
70
Pages
53-68
ISSN
0969-9961 (ISSN-L)
OpenAlex
W2049021349
Cited by
138
References
57
Citations by year
2026: 6 · 2025: 9 · 2024: 22 · 2023: 9 · 2022: 13 · 2021: 20 · 2020: 9 · 2019: 12 · 2018: 14 · 2017: 12 · 2016: 7 · 2015: 4 · 2013: 1
FWCI
2.66
Type
journal article
Language
en
Open access
Locations
  • Neurobiology of Disease (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Independent Social Research Foundation
  • International Foundation for CDKL5 Research
Topics
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Health Sciences › Medicine › Psychiatry and Mental health › Epilepsy research and treatment
Keywords
CDKL5, Rett syndrome, brain development, dentate gyrus, dendritic growth, neuronal apoptosis, neural precursor proliferation, Akt/GSK-3β signaling, hippocampal-dependent memory, X-linked neurodevelopmental disorder
MeSH terms
Glycogen Synthase Kinase 3 beta, Animals, Cell Survival, Cells, Cultured, Dendrites, Female, Male, Neurons, Signal Transduction, Apoptosis, Protein Serine-Threonine Kinases, Mice, Knockout, Maze Learning, Dentate Gyrus, Glycogen Synthase Kinase 3, Cell Enlargement, Proto-Oncogene Proteins c-akt, Neurogenesis, Neural Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review